11th Annual PEGS Europe
- Á¦11ȸ ´Ü¹éÁú Ç×ü ¿£Áö´Ï¾î¸µ ¼­¹Ô À¯·´ -
ÀÏÁ¤ : 2019³â 11¿ù 18-22ÀÏ
°³ÃÖ: Æ÷¸£Åõ°¥, ¸®½ºº», Lisbon Congress Center

½ºÆù¼­    |   ½ºÆù¼­ ¸®½ºÆ®

ÃÖÁ¾ ¾ÆÁ¨´Ù¸¦ È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù.

PEGS EuropeÀº ´Ü¹éÁú ¿£Áö´Ï¾î¸µ°ú Ç×ü ¿£Áö´Ï¾î¸µÀÇ ¸ðµç Ãø¸éÀ» ´Ù·ç´Â À¯·´ ÃÖ´ë ±Ô¸ðÀÇ À̺¥Æ®ÀÔ´Ï´Ù. 2018³â¿¡ Æ÷¸£Åõ°¥ ¸®½ºº»¿¡¼­ °³ÃÖµÈ ¼­¹Ô¿¡´Â ¼¼°è 36°³±¹¿¡¼­ 1,100¿© ¸í(70%´Â Á¦¾à ¾÷°è ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ¾÷°è °ü·Ã Á¶Á÷¿¡ ¼Ò¼Ó)ÀÌ Âü°¡ÇßÀ¸¸ç, ÀÌ ºÐ¾ßÀÇ »õ·Î¿î Áøº¸ µî¿¡ ´ëÇØ ³íÀÇÇß½À´Ï´Ù. 2019³â À̺¥Æ®´Â ÁúÀû·¾çÀû Ãø¸éÀ» ¸ðµÎ °­È­ÇÕ´Ï´Ù.

  • ¾à 1,300¸íÀÇ Âü°¡ÀÚ
  • ¾à 260¸íÀÇ ¿¬»ç
  • ¹®Á¦ ÇØ°áÀ» Áö¿øÇÏ´Â 25°³ÀÇ ±×·ì Åä·Ð
  • ¾à 250°ÇÀÇ Æ÷½ºÅÍ ¹ßÇ¥
  • 100¿© °³ÀÇ ÁÖ¿ä ±â¾÷ ¹× ´Üü°¡ ½ºÆù¼­ ¹× Àü½Ã±â¾÷À¸·Î Âü°¡
  • ³×Æ®¿öÅ·À» ¸ñÀûÀ¸·Î ÇÑ °¢Á¾ À̺¥Æ®
  • Àü½Ãȸ¿Í Æ÷½ºÅÍ ¹ßÇ¥ °ü¶÷ ½Ã°£ÀÇ È®º¸

¼îÆ®ÄÚ½º

¾ç¹æÇâÀ¸·Î ÀǰßÀ» ±³È¯Çϸ鼭 ½ÇÁ¦·Î ÀÛ¾÷À» ½ÃÇàÇÏ´Â ÇüÅ·ΠÁøÇàµÇ´Â ¼îÆ®ÄÚ½º¿¡¼­´Â Á¤º¸ ÆÄ¾Ç°ú ³×Æ®¿öÅ·ÀÌ °¡´ÉÇϸç, ¸®½ºº»¿¡¼­ º¸³»´Â ½Ã°£À» ÇÑÃþ ´õ À¯ÀÍÇÏ°Ô ÇÕ´Ï´Ù. ¼îÆ®ÄÚ½º¿¡¼­´Â °ü·Ã »êÇаèÀÇ ÁÖ¿ä ¿¬±¸ÀÚ°¡ µîÀåÇÏ¿© ´Ü¹éÁú ¿£Áö´Ï¾î¸µ°ú Ç×ü ¿£Áö´Ï¾î¸µ ºÐ¾ßÀÇ ÇöÀç ÇÖÅäÇÈ¿¡ ´ëÇØ °­ÀÇÇÕ´Ï´Ù.

> ¼îÆ®ÄÚ½º


¿¬¼ö ¼¼¹Ì³ª
Cambridge Healthtech Institute(CHI)ÀÇ ¿¬¼ö ¼¼¹Ì³ª¿¡¼­´Â ½ÇÁ¦ ÇÁ·ÎÁ§Æ®ÀÇ »ç·Ê ¿¬±¸, ÇöÀç±îÁö Á÷¸éÇÑ ¹®Á¦¿Í ÀÌ¿ëµÈ ´ëÃ¥ µî°ú °³º° ÅäÇÈ¿¡ °üÇÑ ±âº» Á¤º¸µµ Æø³Ð°Ô ´Ù·ê ¿¹Á¤ÀÔ´Ï´Ù. °æÇèÀÌ Ç³ºÎÇÑ Àü¹®°¡°¡ °­»ç¸¦ ´ã´çÇÏ´Â ¼¼¹Ì³ª¿¡¼­´Â °­ÀÇ, ¾ç¹æÇâ ³íÀÇ, ÀÛ¾÷ µîÀ» ÅëÇØ ¸¹Àº Á¤º¸¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¬¼ö ¼¼¹Ì³ª´Â Á¦¾à¾÷°èÀÇ ´Ù¾çÇÑ Ãø¸é¿¡ °üÇÑ ½ÉÃþ ÇØ¼³À» µéÀ» ¼ö ÀÖ´Ù´Â Á¡¿¡¼­ ±â¾÷ ¹× ´ëÇÐÀÇ ¿¬±¸ ±×·ì¿¡ ¼Ò¼ÓµÈ ½ÅÁø ¿¬±¸ÀÚ ¹× º¸Á¶ ½ºÅÇ¿¡°Ô ¸Å¿ì À¯ÀÍÇÕ´Ï´Ù.

> ¿¬¼ö ¼¼¹Ì³ª

2019³â Àüü ±âÁ¶ °­¿¬

Ä¡·á¸¦ À§ÇÑ »õ·Î¿î Ç÷§ÆûÀ¸·Î¼­ÀÇ ÀÌÁ߯¯À̼º °¡¿ë¼º T¼¼Æ÷ ¼ö¿ëü
Bahija Jallal, PhD, CEO and Director of the Board, Immunocore
ÀçÁ¶ÇÕ Ç×ü¿¡ ÀÇÇÑ ¾Ï¼¼Æ÷ ¼­ÆÄ½Ã¿È(Surfaceomes)¿¡ ´ëÇÑ °ø°Ý
James A. Wells, PhD, Professor, Departments of Pharmaceutical Chemistry and Cellular & Molecular Pharmacology, University of California, San Francisco

Áö³­ ¼­¹Ô Âü°¡ÀÚ ¼Ò°¨

¡°The best biologics technology meeting in Europe: a must-attend conference for novel biologics.¡±
- Rakesh D., PhD, VP, MedImmune

¡°I was very much impressed by the quality of the event, the depth and breadth of the presentations, as well as the scientific discussions and excitement. This is the event to participate and enjoy.¡±
- Yan Q., PhD, Senior Principal Scientist, Rinat Pfizer

"The best protein engineering conference in Europe! The breadth of topics was truly impressive, with excellent talks, discussions as well as networking on everything from details of sophisticated protein engineering to updates on recent clinical studies of new biologics. A must go!¡±
- John L., PhD, Associate Professor, KTH Royal Institute of Technology

¡°Once more PEGS Europe was a great event, packed with know-how knowledge, and networking at its best.¡±
- Philipp M., PhD, Principal Scientist, Boehringer Ingelheim Pharma GmbH & Co. KG

¡°You really have the ability to put together diverse and interesting speakers together with real data – not just sales pitch data! I hope all enjoyed as much as I did.¡±
- Denise F., MD, PhD, Director, Massachusetts General Hospital, and Associate Professor, Harvard Medical School

¡°PEGS Europe is the place to be for everyone working on antibodies and next generation biologics.¡±
- Martin B., PhD, Head, Biochemical and Analytical Research, Roche

> Âü°¡ÀÚ ¼Ò°¨ ´õº¸±â